Fair point Woody. After reading my post I realised what a miserable bugger I am. I'll try to keep the posts positive next time. Scoping study should be a cracker, probably the best Cu development story on the ASX at the moment.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025